Avantor (AVTR) Total Non-Current Liabilities (2018 - 2026)
Avantor (AVTR) posted quarterly Total Non-Current Liabilities of $5.6 billion for Q2 2026, down 8.47% year-over-year from $6.1 billion in Q2 2025, and down 2.01% quarter-over-quarter from $5.7 billion in Q1 2026.
Avantor (AVTR) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $5.6 billion for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 8.47% year-over-year to $5.6 billion; the TTM figure through Jun 2026 stood at $5.6 billion (down 8.47% YoY), while the FY2025 annual figure was $5.9 billion, up 0.9% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $5.6 billion, down from $5.7 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $9.1 billion in Q1 2022, with the low at $5.6 billion in Q2 2026.
- The 5-year median for Total Non-Current Liabilities is $7.0 billion (2024), against an average of $7.0 billion.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities soared 38.98% in 2022, then declined 21.31% in 2024.
- Avantor's Total Non-Current Liabilities stood at $8.3 billion in 2022, then slipped by 11.35% to $7.4 billion in 2023, then decreased by 21.31% to $5.8 billion in 2024, then grew by 0.9% to $5.9 billion in 2025, then dropped by 4.59% to $5.6 billion in 2026.
- Business Quant data shows AVTR's Total Non-Current Liabilities at $5.6 billion in Q2 2026, $5.7 billion in Q1 2026, and $5.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Avantor | 9.62 Bn | 9.31 Bn | 537.00 Mn | 5.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.58 Bn |
| Mar 31, 2026 | 5.70 Bn |
| Dec 31, 2025 | 5.85 Bn |
| Sep 30, 2025 | 5.70 Bn |
| Jun 30, 2025 | 6.10 Bn |
| Mar 31, 2025 | 5.86 Bn |
| Dec 31, 2024 | 5.80 Bn |
| Sep 30, 2024 | 6.87 Bn |
| Jun 30, 2024 | 6.90 Bn |
| Mar 31, 2024 | 7.07 Bn |
| Dec 31, 2023 | 7.37 Bn |
| Sep 30, 2023 | 7.43 Bn |
| Jun 30, 2023 | 7.78 Bn |
| Mar 31, 2023 | 8.10 Bn |
| Dec 31, 2022 | 8.31 Bn |
| Sep 30, 2022 | 8.19 Bn |
| Jun 30, 2022 | 8.61 Bn |
| Mar 31, 2022 | 9.12 Bn |
| Dec 31, 2021 | 9.34 Bn |
| Sep 30, 2021 | 7.69 Bn |